Edition:
India

Nichi-Iko Pharmaceutical Co Ltd (4541.T)

4541.T on Tokyo Stock Exchange

1,732JPY
7:59am IST
Change (% chg)

¥19 (+1.11%)
Prev Close
¥1,713
Open
¥1,716
Day's High
¥1,732
Day's Low
¥1,715
Volume
168,900
Avg. Vol
381,234
52-wk High
¥1,895
52-wk Low
¥1,598

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep 45,784.00 8.595
Jun 48,513.00 34.850
FY 2017 Mar '17 46,097.00 30.680
Dec 42,124.00 15.516
Sep 37,122.00 3.114
Jun 38,029.00 34.576
FY 2016 Mar '16 35,193.00 9.822
Dec 39,333.00 113.882
Sep 33,938.00 22.000
Jun 35,049.00 38.309
 
*Note: Units in Millions ofYen
**Note: Units in Yen

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Mar-18 3 200,267.00 201,100.00 198,800.00 213,040.00
Year Ending Mar-19 3 217,400.00 226,400.00 211,800.00 238,240.00
Earnings (per share)
Year Ending Mar-18 4 112.90 147.54 98.50 134.68
Year Ending Mar-19 4 125.05 154.65 99.50 159.70
Sales and Profit Figures in Japanese Yen (JPY);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 20.98 31.10 32.90
P/E High - Last 5 Yrs. 25.13 40.98 46.03
P/E Low - Last 5 Yrs. 14.11 23.80 24.39
Beta 0.70 0.90 0.89
Price to Sales (TTM) 0.62 3.98 5.45
Price to Book (MRQ) 1.17 4.82 5.38
Price to Tangible Book (MRQ) -- 5.57 6.89
Price to Cash Flow (TTM) 7.97 23.02 23.43
% Owned Institutions -- 1.23 2.16

Dividends

  Company industry sector
Dividend Yield 1.70 1.56 1.50
Dividend Yield - 5 Year Avg 1.26 1.57 1.51
Dividend 5 Year Growth Rate -- 4.35 5.23
Payout Ratio(TTM) 35.98 45.67 43.58

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 27.57 3.59 9.01
Sales (TTM) vs TTM 1 Yr. Ago 18.68 4.69 5.44
Sales - 5 Yr. Growth Rate -- 10.10 10.34
EPS (MRQ) vs Qtr. 1 Yr. Ago 0.79 16.23 19.33
EPS (TTM) vs TTM 1 Yr. Ago -53.32 -- --
EPS - 5 Yr. Growth Rate -- 9.86 10.77
Capital Spending - 5 Yr. Growth Rate -- 15.30 15.26

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.54 2.11 2.18
Current Ratio (MRQ) 1.36 2.88 2.97
LT Debt to Equity (MRQ) 100.21 9.81 12.10
Total Debt to Equity (MRQ) 137.85 13.80 16.38
Interest Coverage (TTM) -- 36.25 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 34.14 55.13 54.76
Gross Margin - 5 Yr. Avg. 37.01 52.41 52.45
EBITD Margin (TTM) 10.00 -- --
EBITD - 5 Yr. Avg 11.83 18.54 15.33
Operating Margin (TTM) 4.26 14.40 7.60
Operating Margin - 5 Yr. Avg. 7.19 14.46 10.79
Pre-Tax Margin (TTM) 4.32 14.82 8.38
Pre-Tax Margin - 5 Yr. Avg. 7.44 14.77 11.19
Net Profit Margin (TTM) 2.73 11.09 4.70
Net Profit Margin - 5 Yr. Avg. 5.09 11.11 7.50
Effective Tax Rate (TTM) 36.73 23.16 23.05
Effective Tax Rate - 5 Yr. Avg. 31.64 23.40 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 120,901,200 948,195,516 855,725,045
Net Income/Employee (TTM) 3,303,894 111,561,295 100,665,187
Receivable Turnover (TTM) 6.74 5.61 5.76
Inventory Turnover (TTM) 1.94 2.57 3.34
Asset Turnover (TTM) 0.82 0.95 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 2.25 11.41 10.97
Return on Assets - 5 Yr. Avg. 4.51 12.98 12.39
Return on Investment (TTM) 3.50 14.84 14.40
Return on Investment - 5 Yr. Avg. 7.10 16.97 16.20
Return on Equity (TTM) 5.89 16.32 16.09
Return on Equity - 5 Yr. Avg. 9.49 18.05 17.53
  1 Year 3 Year 5 Year
Sales % 13.84 16.39 --
EPS (TTM) % -54.38 -7.08 --
Dividend % 12.78 6.62 --
Note: Units in Millions of US Dollars

Performance for Nichi-Iko Pharmaceutical Co Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 8.21 2.21 77 25
13 Week 0.86 -3.93 61 36
26 Week -0.23 -11.90 56 31
52 Week -9.99 -27.77 38 12
YTD 5.62 -4.93 53 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 17.70%
# of Holders: 63
Total Shares Held: 10,734,590
3 Mo. Net Change: 375,512
# New Positions: 0
# Closed Positions: 2
# Increased Positions: 15
# Reduced Positions: 6
# Net Buyers: 9
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.